Coronavirus (COVID-19) News and Resources
Coronavirus (COVID-19) Webcasts
Subscribe to Free Daily Newsletters
Post a Job

Featured Jobs

ESOP Valuation Writer
Unique ESOP Valuation Provider
Enrolled Actuary
Loren D. Stark Company logo
Loren D. Stark Company

Free Daily News and Jobs

“BenefitsLink continues to be the most valuable resource we have at the firm.”

-- An attorney subscriber

Get the BenefitsLink app LinkedIn

<< Previous news item   |   Next news item >>

A 10-Year Projection of the Prescription Drug Share of National Health Expenditures, Including Non-Retail (PDF)
Altarum Institute Link to more items from this source
Oct. 13, 2014
"Because the growth in spending on traditional drugs has been slow and the non-retail share has been quite steady, it is useful to focus attention initially on specialty drugs. The most important question is whether the recent historical decline in the non-retail share of spending on specialty drugs is likely to continue."

Please click here to report this link if it is broken (for example, if you see a "404 File Not Found" error message after you click on the link above).
An important word about authorship: BenefitsLink® is providing a hypertext link to the item shown above, but is not the author of the item (unless otherwise specified).
© 2020, Inc.